We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+11.56%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$29B
AUM Growth
+$1.31B
Cap. Flow
-$909M
Cap. Flow %
-3.13%
Top 10 Hldgs %
15.23%
Holding
609
New
89
Increased
190
Reduced
216
Closed
75

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$186M
2
AMZN icon
Amazon
AMZN
+$156M
3
ADBE icon
Adobe
ADBE
+$136M
4
CMCSA icon
Comcast
CMCSA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$125M

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Healthcare 15.88%
3 Industrials 13.56%
4 Financials 10.64%
5 Consumer Discretionary 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GM icon
76
General Motors
GM
$81.7B
$109M 0.37%
2,817,053
-1,899
-0.1% -$65.7K
UL icon
77
Unilever
UL
$144B
$105M 0.36%
1,793,548
+61
+0% +$3.62K
SNPS icon
78
Synopsys
SNPS
$73.5B
$105M 0.36%
240,790
+228,575
+1,871% +$92.1M
AMAT icon
79
Applied Materials
AMAT
$378B
$105M 0.36%
723,166
-1,389
-0.2% -$174K
DT icon
80
Dynatrace
DT
$12.7B
$104M 0.36%
2,022,141
+321,533
+19% +$15.1M
PLD icon
81
Prologis
PLD
$137B
$104M 0.36%
846,222
+75,673
+10% +$9.31M
KLAC icon
82
KLA
KLAC
$249B
$103M 0.36%
2,131,620
-966,900
-31% -$40.4M
CDNS icon
83
Cadence Design Systems
CDNS
$95.1B
$100M 0.34%
426,609
+6,753
+2% +$1.47M
KRYS icon
84
Krystal Biotech
KRYS
$10.7B
$98.9M 0.34%
842,648
-118,594
-12% -$12.1M
DXCM icon
85
DexCom
DXCM
$28.9B
$98.2M 0.34%
764,075
+154,407
+25% +$18.7M
CFLT
86
DELISTED
Confluent
CFLT
$97.4M 0.34%
2,758,042
-51,470
-2% -$1.44M
APLS
87
DELISTED
Apellis Pharmaceuticals
APLS
$97.3M 0.34%
1,068,143
+163,915
+18% +$14.1M
RELY icon
88
Remitly
RELY
$4.91B
$95.4M 0.33%
5,067,719
+731,295
+17% +$13.3M
BJ icon
89
BJs Wholesale Club
BJ
$12.4B
$94.7M 0.33%
1,502,543
-6,636
-0.4% -$459K
VVV icon
90
Valvoline
VVV
$5.13B
$93.5M 0.32%
2,491,342
-690,058
-22% -$25.1M
CZR icon
91
Caesars Entertainment
CZR
$6.1B
$92.4M 0.32%
1,813,714
-122,018
-6% -$5.54M
PFE icon
92
Pfizer
PFE
$144B
$90.5M 0.31%
2,466,206
-432,990
-15% -$16.9M
DUOL icon
93
Duolingo
DUOL
$6.56B
$89.8M 0.31%
628,509
+36,025
+6% +$5.16M
TSLA icon
94
Tesla
TSLA
$1.21T
$88.8M 0.31%
339,299
+150,370
+80% +$30.1M
BKNG icon
95
Booking.com
BKNG
$154B
$88.6M 0.3%
819,825
-240,825
-23% -$25.4M
MRSH
96
Marsh
MRSH
$91.7B
$87.2M 0.3%
463,561
PANW icon
97
Palo Alto Networks
PANW
$260B
$87.1M 0.3%
681,428
-1,314
-0.2% -$137K
AXON
98
Axon Enterprise
AXON
$44.1B
$86.8M 0.3%
444,797
-120,263
-21% -$24.9M
MPC icon
99
Marathon Petroleum
MPC
$89.3B
$86.5M 0.3%
741,979
-741,139
-50% -$86.2M
MDB icon
100
MongoDB
MDB
$25B
$86M 0.3%
+209,369
New +$61.1M

Similar funds

Lord, Abbett & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Lord, Abbett & Co held 609 positions worth $29B, up 4.7% from $27.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Lord, Abbett & Co withdrew a net $909M in Q2 2023, closing 75 positions and reducing 216 holdings. Its most notable exit was Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B, an estimated $108M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lord, Abbett & Co opened a new position in lululemon athletica worth $77.8M.

  • Lord, Abbett & Co's largest Q2 2023 buy was lululemon athletica: 205,450 shares worth $77.8M.
  • Lord, Abbett & Co added most to Microsoft in Q2 2023, an estimated $186M increase.
  • Lord, Abbett & Co's biggest Q2 2023 reduction was Crocs, cutting an estimated $103M.
  • Lord, Abbett & Co fully exited Danaher Corporation 5.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $108M.
  • Lord, Abbett & Co's ten largest holdings make up 15% of its $29B portfolio in Q2 2023.
  • Lord, Abbett & Co opened 89 new positions and closed 75 in Q2 2023.
  • Lord, Abbett & Co's portfolio value rose 4.7% quarter-over-quarter to $29B.

Based on Lord, Abbett & Co's 13F filing for Q2 2023, filed 14 Aug 2023.